metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology Salmonella sp Group A: A rare cause of bacterascites. A case report
Journal Information
Vol. 7. Issue 3.
Pages 260-261 (July - September 2008)
Share
Share
Download PDF
More article options
Visits
969
Vol. 7. Issue 3.
Pages 260-261 (July - September 2008)
Open Access
Salmonella sp Group A: A rare cause of bacterascites. A case report
Visits
969
Gustavo López-Arce1,
Corresponding author
glopezarce@gmail.com

Address to correspondence:
, Aldo Torre-Delgadillo1, Félix I. Téllez-Ávila1
1 Department of Gastroenterology. Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
This item has received

Under a Creative Commons license
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Tables (1)
Table I. Isolated microorganisms in SBP and BA episodes in the study performed in the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán.
Abstract

Bacterascites (BA) is a minimally studied and defined entity. Its prognosis and clinical course are not well defined, and currently there are no management guidelines. We present a rare cause of BA in which Salmonella sp group A was isolated in a 44 year old man with cirrhosis who had diarrhea and fever three days earlier. Treatment with intravenous ceftriaxone was effective.

Key words:
Spontaneous bacterial peritonitis
cirrhosis
ascites
neutrascites
Full Text
Presentation of case

A 44 year old man was admitted to our hospital because malaise, chills, and abdominal pain. He had a history of non-bloody diarrhea and fever three days earlier. He did not seek medical attention and did not take any medications. He had Child C cirrhosis secondary to non alcoholic steatohepatitis detected incidentally four years before. He had presented since then few events of hepatic encephalopathy grade 2, ascites and leucopenia secondary to hypersplenism by portal hypertension. A contrast echocardiogram performed seven months earlier showed shunts compatible with pulmonary syndrome and he was placed on the liver transplant protocol.

Physical examination on admission revealed a temperature of 39.5°C, a heart rate of 100 beats per minute, a respiratory rate of 20 breaths per minute, and blood pressure of 160/90 mmHg, conjunctival jaundice, and his oral mucosa was dry. Chest examination revealed regular heart sounds, and clear lungs. The abdominal examination noted distension, normal bowel sounds and non-tension ascites with diffuse tenderness on palpation without rebound, and an enlarged spleen. His remarkable laboratory findings were: hemoglobin of 9.0 g/L, white blood cells of 4800 per mm3, with bandemia of 17%, platelets 58,000 per mm3, creatinine 2.3 mg/dL, fractional sodium excretion was of 0.02%. The serum electrolytes, blood cultures and urine analysis were normal. A diagnostic paracentesis was performed and fluid analysis revealed total leucocytes of 190 per mm3. In ascitic culture Salmonella sp group A was isolated. An intravenous Ceftriaxone 1 g/bid for 7 days was administered and favorable clinical evolution was noted.

Discussion

We present an unusual case of BA in which Salmonella sp. group A was isolated in ascitic fluid. To our knowledge, there are no previous case reports about BA secondary to Salmonella. In the present case the ascites was possibly contaminated by bacterial translocation since the patient had diarrhea 3 days earlier. BA is a minimally studied entity, and is defined by the presence of < 250 polymorphonuclear (PMN) cells/mm3 in ascitic fluid and isolation of bacteria in culture in initial paracentesis. The prevalence of SBP is about 10-30% in cirrhotic hospitalized patients1,2 but incidence or prevalence of BA is not well defined. Prospective studies have reported very low prevalence (2.5 to 3%) of BA,4-6 but these studies only included asymptomatic patients with large-volume paracentesis. Other studies report a prevalence about 31% to 37.9% of all positive culture with PMN less than 250 cells/mm3.3 In a prospective study by our group (unpublished data), a BA prevalence of 12.5% was found in 118 patients with ascites assessed in the emergency department.

There is little information about microorganisms isolated in BA. In one study by Pelletier G et al,7 gramnegative bacteria was present in 50% of patients, the principal organisms cultured were Escherichia coli, Klebsiella pneumonie and Enterobacter cloacae in 27% each one. Similar results were obtained by Runyon et al.3 In our center, we observed that Gramnegative microorganisms were isolated more frequently (73.3%) than Grampositive bacteria (26.7%). Table I shows the isolated microorganisms in (spontaneous bacterial peritonitis) SBP and BA in one study performed in our hospital.

Table I.

Isolated microorganisms in SBP and BA episodes in the study performed in the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán.

Organism  SBP patients n (%)  BA patients n (%) 
Escherichia coli  2 (28.5)  11 (73.3) 
Staphylococcus aureus  1 (14.2)  2 (13.3) 
Streptococcus sanguis  1 (14.2)  2 (13.3) 
Enterococcus sp  1 (14.2)   
K. oxytoca  1 (14.2)   
Haemophilus influenzae  1 (14.2)   
TOTAL  7 (100)  15 (100) 
Gram-negative rod  4 (57.1)  11 (73.3) 
Gram-positive cocci  3 (42.9)  4 (26.7) 

SBP: Spontaneous Bacterial Peritonitis; BA: Bacterascites.

The case presented was treated with standard therapy based in current guidelines for SBP because he had signs of systemic infection [8] and we consider that is unethical to deny treatment in these cases, because those patients seem to beneficiate with antibiotic course. Asymptomatic patients are considered as a different situation: Ruynon et al observed that 62% of colonization resolved without antibiotics, but in patients with symptoms of infection they suggest that treatment with empirical antibiotics should be initiated until the culture is known regardless of the PMN count in ascitic fluid.9 In our study, we observed mortality of 33% (5 patients) in BA group with antibiotic treatment in comparison to patients with SBP (33 vs 50% p = 0.53). Patient was discharged from the hospital without signs of infection.

References
[1.]
Caly W.R., Strauss E..
A prospective study of bacterial infections in patients with cirrhosis..
J Hepatol, 18 (1993), pp. 353-358
[2.]
García-Tsao G..
Bacterial infections in cirrhosis: treatment and prophylaxis..
J Hepatol, 42 (2005), pp. S85-S92
[3.]
Runyon B.A..
Monomicrobial nonneutrocytic bacterascites: A variant of spontaneous bacterial peritonitis..
Hepatology, 12 (1990), pp. 710-715
[4.]
Castellote J., Girbau A., Maisterra S., Charhi N., Ballester R., Xiol X..
Spontaneous bacterial peritonitis and bacterascites prevalence in asymptomatic cirrhotic outpatients undergoing large-volume paracentesis..
J Gastroenterol Hepatol, 23 (2008), pp. 256-259
[5.]
Jeffries M.A., Stern M.A., Gunaratnam N.T., Fontana R.J..
Unsuspected infection is infrequent in asymptomatic outpatients with refractory ascites undergoing therapeutic paracentesis..
Am J Gastroenterol, 94 (1999), pp. 2972-2976
[6.]
Romney R., Mathurin P., Ganne-Carrié N., Halimi C., Medini A., Lemaitre P., Gruaud P., et al.
Usefulness of routine analysis of ascitic fluid at the time of therapeutic paracentesis in asymptomatic outpatients. Results of a multicenter prospective study..
Gastroenterol Clin Biol, 29 (2005), pp. 275-279
[7.]
Pelletier G., Lesur G., Ink O., Hagege H., Attali P., Buffet C., Etienne J.P..
Asymptomatic bacterascites: is it spontaneous bacterial peritonitis?.
Hepatology, 14 (1991), pp. 112-115
[8.]
Rimola A., Garcí-Tsao G., Navasa M., Piddock L.J., Planas R., Bernard B., Inadomi J.M..
Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: A consensus document. International Ascites Club..
J Hepatol, 32 (2000), pp. 142-153
[9.]
Runyon B.A..
Management of adult patients with ascites due to cirrhosis..
Hepatology, 39 (2004), pp. 1-16
Copyright © 2008. Fundación Clínica Médica Sur, A.C.
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos